Listed digital medication management company, MedAdvisor, has partnered with the 100% community-funded charity Bowel Cancer Australia (BCA), to raise awareness around early detection and intervention in the treatment of bowel cancer.
MedAdvisor ceo Robert Read said, "The Bowel Cancer Australia partnership enables us to provide important information to those interested in screening according to their personal bowel cancer risk, which varies depending on age, family history, comorbidities and lifestyle factors."
The new partnership will enable patients to use the many adherence functions of the MedAdvisor platform and pharmacists to use it to initiate conversations with patients who may be at risk.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jun 18
